Pancreatic Cancer Market Size Share Growth Opportunities and Forecast 2023-2030

Global Pancreatic Cancer Market Projected to Reach US$ 5.7 Billion by 2030

Market Overview

In 2022, the global pancreatic cancer market surged to US$ 2.5 billion, and projections indicate a substantial growth trajectory, with an anticipated value of US$ 5.7 billion by 2030. The market is poised to exhibit a Compound Annual Growth Rate (CAGR) of 11.1% during the forecast period from 2023 to 2030.

Market Scope

Metrics:

CAGR: 11.1%
Size Available for Years: 2021-2030
Forecast Period: 2023-2030
Data Availability: Value (US$)
Segments Covered: Treatment Type, End User
Regions Covered: North America, Europe, Asia-Pacific, South America, Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Covered:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.

Download Free Sample: https://www.datamintelligence.com/download-sample/pancreatic-cancer-market

Market Dynamics

The rising prevalence of pancreatic cancer is propelling market growth globally. Pancreatic cancer, ranking as the fourth leading cause of cancer fatalities, exhibits higher incidence, prevalence, and mortality rates in nations with high Human Development Indices (HDI). Factors such as obesity, passive smoking, and chronic inflammation contribute to the increased incidence of pancreatic cancer.

FDA approvals for new products, such as MT-601, indicate a positive trend in the market. However, the market faces challenges due to side effects associated with therapeutics, impacting growth.

Segment Analysis

The global pancreatic cancer market is segmented based on treatment type, end-user, and region. Chemotherapy holds a dominant position, contributing approximately 37.6% to the market in 2022, with popular medications including Gemcitabine, 5-fluorouracil (5-FU), and Oxaliplatin.

To know more insights: https://www.datamintelligence.com/research-report/pancreatic-cancer-market

Geographical Penetration

North America commands a significant share, estimated at 39.3%, driven by rising pancreatic cancer cases and advancements in treatment and diagnosis.

Competitive Landscape

Key players in the global market include Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Amgen Inc., Viatris Inc., Boston Scientific Corporation, Clovis Oncology, and GlaxoSmithKline.

By Treatment Type:
Targeted Therapies
Chemotherapy
Surgery
Other Treatments

By End-user:
Hospitals
Specialty Clinics
Home Care
Others

By Region:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
South America (Brazil, Argentina, Rest of South America)
Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific)
Middle East and Africa

Related Reports:

Locally Advanced Pancreatic Cancer Market: https://www.datamintelligence.com/research-report/locally-advanced-pancreatic-cancer-market

Exocrine Pancreatic Insufficiency Market: https://www.datamintelligence.com/research-report/exocrine-pancreatic-insufficiency-market

Artificial Pancreas Market: https://www.datamintelligence.com/research-report/artificial-pancreas-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.